Browse Category

NYSE:GIB News 27 January 2026

Vodafone share price slips as Centrica partnership lands — and buyback rolls on

Vodafone share price slips as Centrica partnership lands — and buyback rolls on

Vodafone shares fell 0.3% to 104.2 pence in early London trading, retreating from Monday’s 52-week high. The company signed a four-year workplace and connectivity contract with Centrica, covering 80 UK sites and 30,000 devices. Vodafone also repurchased 2.57 million shares on Jan. 26 at an average 104.82 pence each. Financial terms of the Centrica deal were not disclosed.
27 January 2026

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop